Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
AbbVie
(NY:
ABBV
)
168.59
+2.03 (+1.22%)
Official Closing Price
Updated: 4:10 PM EDT, Jun 14, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about AbbVie
< Previous
1
2
...
17
18
19
20
21
22
23
24
25
...
55
56
Next >
If You Invested $1000 In This Stock 10 Years Ago, You Would Have $3,200 Today
May 23, 2023
Via
Benzinga
Why Ironwood Pharmaceuticals Stock Bumped Higher Today
May 22, 2023
Investors indicated approval of the company's upcoming $1 billion asset purchase.
Via
The Motley Fool
AbbVie Unusual Options Activity
May 22, 2023
Via
Benzinga
VectivBio Stock Catapults 38% After Ironwood Agrees To Buy It For $1 Billion
May 22, 2023
Both companies are working on treatments for gastrointestinal diseases.
Via
Investor's Business Daily
3 Relatively Safe Stocks to Buy if a Recession Is on the Way
May 20, 2023
If the economy falters, these stocks should hold up better than most.
Via
The Motley Fool
3 No-Brainer Dividend Stocks to Buy With $1,000 Right Now
May 20, 2023
The decisions are easy with these dividend stocks.
Via
The Motley Fool
FDA Approves AbbVie/Genmab's Cancer Drug As First Bispecific Antibody For Type Of Lymphoma In Adult Patients
May 19, 2023
The FDA has approved Epkinly (epcoritamab-bysp) as the first and only T-cell engaging bispecific antibody for adult patients with relapsed or refractory (R/R) diffuse large B-cell lymphoma (DLBCL)...
Via
Benzinga
What Does AbbVie's Debt Look Like?
May 17, 2023
Via
Benzinga
This Is What Whales Are Betting On AbbVie
May 17, 2023
Via
Benzinga
P/E Ratio Insights for AbbVie
May 17, 2023
Via
Benzinga
FDA Approves First Oral Treatment For Crohn's Disease, Making Seventh Approval For AbbVie's Rinvoq
May 19, 2023
The FDA approved AbbVie Inc's (NASDAQ: ABBV) Rinvoq (upadacitinib) for moderately to severely active Crohn's disease patients with inadequate response or intolerance to
Via
Benzinga
Apple Thwarts $2B In Fraud Transactions, UBS Takes $17B Hit From 'Hasty Credit Suisse Takeover,' Verizon Streamlines Unlimited Data Plans: Today's Top Stories
May 17, 2023
Benzinga
Via
Benzinga
One More Quits US Pharma Lobby Group: AstraZeneca Follows Teva, AbbVie Footsteps
May 17, 2023
AstraZeneca Plc (NASDAQ: AZN) has decided to leave a U.S. drug lobby group, the Pharmaceutical Research and Manufacturers of America (PhRMA), making it the third company to leave the group in the last...
Via
Benzinga
Peering Into AbbVie's Recent Short Interest
May 16, 2023
Via
Benzinga
Pfizer CEO Fires Back On US Drug Pricing Reforms: 'Negotiation with a Gun to Your Head'
May 12, 2023
Pfizer Inc's (NYSE: PFE) CEO Albert Bourla called U.S. plans to negotiate drug prices for its Medicare health program "negotiation with a gun to your head."
Via
Benzinga
This Is What Whales Are Betting On AbbVie
May 11, 2023
Via
Benzinga
This Analyst Likes Evolus As 'Top Play In Aesthetics'
May 10, 2023
Evolus Inc (NASDAQ: EOLS) will be the exclusive U.S.
Via
Benzinga
Why Viking Therapeutics Stock Wobbled Today
May 09, 2023
The biotech's shares dipped along with the broader markets in early-morning trading today.
Via
The Motley Fool
Is ChatGPT A Better Financial Advisor? We're Going To Find Out
May 10, 2023
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
May 10, 2023
Via
Benzinga
Why Enanta Shares Are Plunging Today
May 09, 2023
Enanta Pharmaceuticals Inc's (NASDAQ: ENTA) investigational COVID-19 pill, EDP-235, met its primary endpoints of safety and tolerability in its Phase 2 SPRINT trial but yielded
Via
Benzinga
Looking At AbbVie's Recent Unusual Options Activity
May 08, 2023
Via
Benzinga
Here's How Much $1000 Invested In AbbVie 10 Years Ago Would Be Worth Today
May 05, 2023
Via
Benzinga
GlycoMimetics: A Breakthrough In Hematopoietic Stem Cell Transplantation
May 09, 2023
Blood cancers such as AML, MM, and MDS affect a terrible toll on patients and their loved ones. Glycomimetics may be such a company that can offer patients suffering from various blood cancers hope...
Via
Talk Markets
Check Out 3 Health Care Stocks With Over 3% Dividend Yields From Wall Street's Most Accurate Analysts
May 09, 2023
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high...
Via
Benzinga
7 Dividend Stocks That Will Pay You Through Any Market Turmoil
May 08, 2023
With market conditions looking rather worrying, anxious investors turn to the best dividend stocks for market crash list.
Via
InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
May 08, 2023
Via
Benzinga
1 Relatively Safe Dividend Growth Stock to Buy Hand Over Fist Right Now
May 06, 2023
Look past the bad news, at how this company will perform in the future.
Via
The Motley Fool
Looking for Steady, Passive Income? Buy AbbVie Stock
May 06, 2023
The drugmaker looks poised to rebound from its Humira loss of exclusivity.
Via
The Motley Fool
3 Great Income Stocks That Retirees Should Love
May 06, 2023
If you're looking for additional retirement income, these three stocks should be right up your alley.
Via
The Motley Fool
< Previous
1
2
...
17
18
19
20
21
22
23
24
25
...
55
56
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.